FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer (PaFLO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2012 by Charite University, Berlin, Germany
Sponsor:
Information provided by (Responsible Party):
P. C. Thuss-Patience, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01503372
First received: December 22, 2011
Last updated: January 10, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)